Articles

Breast cancer survivors who suffer from depression can safely take both tamoxifen and a concomitant selective serotonin reuptake inhibitor (SSRI) antidepressant, according to a large population-based observational study presented at the 2013 annual meeting of the Multinational Association of Supportive Care in Cancer. Read More ›

A 66-year-old female with newly diagnosed non-small cell lung cancer (NSCLC) presents to clinic. She is diagnosed with a stage IV adenocarcinoma. She was previously treated at an outside institution with pemetrexed in a clinical trial. Read More ›

This article describes sources of workplace contamination with hazardous drugs and how healthcare workers may be exposed to hazardous drugs during the course of their duties. Read More ›

Further analyses of Study 301, which compared eribulin to capecitabine in the treatment of advanced breast cancer, showed greater improvements in quality of life (QOL) with eribulin, and overall survival (OS) benefits in subsets of patients. Read More ›

“Wow, those meetings must be sober events.” I’ve gotten this and other similar comments regularly over the past 6½ years since I received my diagnosis of stage III breast cancer in 2007. Fortunately for me and many other women, the assumption couldn’t be less accurate. Read More ›

October is National Breast Cancer Awareness Month. The September 30, 2013, presidential proclamation acknowledging this points out that “This disease touches every corner of the United States—in 2013 alone, more than 230,000 women and over 2,000 men will be diagnosed with breast cancer, and tens of thousands will die from it.” Read More ›

Would I have a chance to be accepted, as I did not technically qualify as a “breast cancer activist,” was the thought that raced through my mind as I viewed the following description on the National Breast Cancer Coalition (NBCC) website? Read More ›

Patients with cancer face many challenges, including eating well to maintain a good nutritional status and avoid weight loss and malnutrition. Read More ›

The word survivor has come to be widely identified and associated with words such as courage, heroine, brave, and fighter. Thus, it might surprise many that this socially endeared title is often debated in the breast cancer community. Read More ›

Building Bridges to Con­quer Cancer, the theme of the 2013 annual American Society of Clinical Oncology (ASCO) meeting held in Chicago, IL, is an appropriate goal of all healthcare practitioners who specialize in hematology/oncology, including postgraduate year 2 (PGY-2) oncology pharmacy residents. Read More ›